Internal Medicine, Gastroenterology · Leesburg, FL
NPI
1366493652
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
822 Perkins St
Leesburg, FL, 34748
Phone (352) 315-4111
Groups this clinician bills Medicare through
Medicare paid, 2024
$371K
3,626 services
Medicare patients, 2024
1,776
Average age 75
Drug cost, 2024
$1.8M
4,612 prescriptions
Company payments, 2025
$910
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nehme Gabriel was code 43239 (upper gi endoscopy), 671 times for 641 patients. In total Nehme Gabriel billed 3,626 services in 49 codes, and Medicare paid $371K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 43239 Upper GI Endoscopy | Facility | 671 | 641 | $51.92 | $35K |
| 45385 Colonoscopy - Lesion Removal | Facility | 488 | 483 | $188.45 | $92K |
| 99214 Office E&M - Established | Office | 433 | 366 | $93.02 | $40K |
| 99213 Office E&M - Established | Office | 409 | 371 | $65.97 | $27K |
| 45380 Lower GI Endoscopy - Other | Facility | 355 | 353 | $65.94 | $23K |
| 99203 Office E&M - New | Office | 201 | 201 | $82.99 | $17K |
| 43248 Upper GI Endoscopy | Facility | 188 | 185 | $96.70 | $18K |
| 99204 Office E&M - New | Office | 159 | 159 | $121.59 | $19K |
| 43251 Upper GI Endoscopy | Facility | 84 | 82 | $128.98 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 75 | 42 | $61.83 | $4,637 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 73 | 73 | $171.77 | $13K |
| 45378 Lower GI Endoscopy - Other | Facility | 54 | 54 | $114.94 | $6,207 |
| 99222 Hospital E&M - Initial | Facility | 50 | 46 | $103.05 | $5,153 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 49 | 49 | $168.04 | $8,234 |
| 91110 Standard X-ray | Office | 47 | 47 | $516.18 | $24K |
By year: 2022 $469K for 4,672 services; 2023 $390K for 3,868 services; 2024 $371K for 3,626 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nehme Gabriel prescribed most often to Medicare patients was Sod Sulf-Potass Sulf-Mag Sulf (Sodium, Potassium,mag Sulfates), with 831 prescriptions and refills. In total Nehme Gabriel wrote 4,612 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 831 | 831 | 817 | $51K |
| Pantoprazole Sodium Generic | 647 | 1,838 | 313 | $9,510 |
| Famotidine Generic | 521 | 1,488 | 247 | $12K |
| Omeprazole Generic | 514 | 1,473 | 221 | $9,204 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 174 | 174 | 164 | $2,994 |
| Dicyclomine Hcl Generic | 169 | 454 | 87 | $5,308 |
| Linzess Linaclotide | 153 | 347 | 71 | $182K |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 145 | 145 | 145 | $21K |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 130 | 130 | 129 | $22K |
| Colestipol Hcl Generic | 102 | 264 | 56 | $19K |
| Colesevelam Hcl Generic | 97 | 269 | 51 | $21K |
| Sucralfate Generic | 96 | 181 | 50 | $10K |
| Mesalamine Generic | 70 | 139 | 22 | $21K |
| Esomeprazole Magnesium Generic | 68 | 182 | 27 | $2,610 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 41 | 41 | 40 | $745 |
Brand drugs: 1,053 claims; generic drugs: 3,559 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nehme Gabriel $910 ($910 in general payments such as food, travel and fees) from 14 companies. The largest payer was Janssen Biotech, Inc. with $326.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 10 | $326 |
| Madrigal Pharmaceuticals MDGL | 3 | $94.48 |
| Abbvie Inc. ABBV | 4 | $81.01 |
| NeurAxis, Inc. NRXS | 1 | $76.14 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $47.32 |
| Novo Nordisk Inc NVO | 2 | $44.51 |
| Ardelyx, Inc. ARDX | 2 | $42.79 |
| Intercept Pharmaceuticals, Inc. | 2 | $42.15 |
| Aimmune Therapeutics, Inc. | 2 | $40.51 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $35.46 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.